MedPath

乐泰药业有限公司

Ownership
-
Established
2005-08-04
Employees
-
Market Cap
-
Website
www.hrblt.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

72

NMPA:72

Drug Approvals

Mirabegron Sustained-release Tablets

Product Name
米拉贝隆缓释片
Approval Number
国药准字H20253163
Approval Date
Jan 14, 2025
NMPA

Finasteride Tablets

Product Name
非那雄胺片
Approval Number
国药准字H20253091
Approval Date
Jan 8, 2025
NMPA

Finasteride Tablets

Product Name
非那雄胺片
Approval Number
国药准字H20253092
Approval Date
Jan 8, 2025
NMPA

消癌平片

Approval Number
国药准字Z20044046
Approval Date
Jul 9, 2024
NMPA

Silodosin Capsules

Product Name
赛洛多辛胶囊
Approval Number
国药准字H20244076
Approval Date
Jun 18, 2024
NMPA

更年乐胶囊

Approval Number
国药准字Z20090821
Approval Date
Mar 19, 2024
NMPA

颈康胶囊

Approval Number
国药准字Z20090833
Approval Date
Mar 19, 2024
NMPA

通窍鼻炎片

Approval Number
国药准字Z20093519
Approval Date
Feb 26, 2024
NMPA

Compound Benzoic Acid Tincture

Product Name
复方苯甲酸酊
Approval Number
国药准字H20093588
Approval Date
Dec 27, 2023
NMPA

Zinc Gluconate Oral Solution

Product Name
葡萄糖酸锌口服溶液
Approval Number
国药准字H20093614
Approval Date
Dec 27, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.